% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • golf.paul123 golf.paul123 Jul 1, 2014 12:55 PM Flag

    It's Been Awhile Since I've Checked In

    Still looks pretty dreary. I bought this POS at $17.75 and fortunately sold it at $13.95. Looks like the best thing to do here is get out while you can before you ride it all the way down. I made that mistake with ISCO. Bought at .21 and sold at .08. Lost a couple of grand. Doesn't seem like this company has much future. I'd get out before it goes below $10.

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This is a small time stock trying very hard to break into the major league. Unfortunately many investors still think the IMGN officers exist soley to do the bidding of small investors.

      My opinion is if you hold more than 10% of the total float, you might be able to get an ear of an officer or a member of the board.

      Demanding that officers take action to directly move the stock price is inherently unethical and dangerous for everyone.

      Can/should investors demand IMGN seek partnerships or suitors for a takeover? I think IMGN actively seeking either would detract from getting the best price or terms. Due dilligence can take years while lawyers hash out the details and it's remarkably immature to demand it, not knowing what is going on the minds of the management.

      Sentiment: Buy

      • 1 Reply to waheed_jaqueed
      • IMGN officers have done nothing for any of the shareholders, after 25 years the stock has gone no where. Job #1 is to improve shareholder value and the stock price and in that regard they are failing. It's time for the BOD to look at an exit strategy, or replace the failed leader(s). No Bus Dev sonce 2011, no progress in the pipeline for the past year, the list goes on and on.

    • You should have bought shares early this morning because this will be higher than 17 by year end. $10 Jan call options are still cheap.

    • IMGN is no penny stock, it's a real Biotech Company with great asset value. This MS Analyst has an agenda. You should have averaged down on IMGN, it will be back above your purchase price!

      Sentiment: Buy

7.64-0.34(-4.26%)Feb 5 4:00 PMEST